Drug Approval | September 21, 2022
Tezspire approved in the EU for the treatment of severe asthma
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
Quinten Health will announce in the coming months strategic partnerships with big pharma companies and data owners to launch the first disease modeling platforms.
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Apollo Pharmacy has over 50% market share amongst India’s organized pharmacies
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Subscribe To Our Newsletter & Stay Updated
